Wednesday 31st July 2019
|
9:00 |
Registration and Refreshments |
9:30 |
Welcome by Alan Langlands |
9:45 |
Sponsor Talks: RSS/YSS and Lubrizol |
10:30 |
Plenary Talk: “Recurrent events analysis: methodological developments and regulatory challenges“ by Jennifer Rogers |
11:30 |
Break and Refreshments with Posters and Sponsors |
11:50 |
Parallel Session 1
- Multi-State Modelling Chair: David Hughes
- Isabelle Smith: Implications on Sample Size and Power When Using Multi-State Models to Analyse Pressure Ulcer Prevention Trials
- Micki Hill: Relaxing the Constant Hazard Assumption in a Multi-State Model in Hospital Epidemiology
- Michael Barrowman: Validation Measures in Multi-State Clinical Prediction Models
- Ryan Jessop: Analysis of Clickstream Data
- Machine Learning and Big Data Chair: Iva Budimir
- Nicholas Peckham: Using Cluster Analysis to Group Countries Based on Non-Communicable Disease Risk Factors
- Max Stockdale: Updating a Business Survey Sampling Frame Using Machine Learning
- Emma Pritchard: Comparing the Sensitivity of Data Input in Clustering Methods to Describe Deaths in Oxfordshire
- Callum Vyner: Divide-and-Conquer Monte Carlo – Marginal Views
|
13:10 |
Buffet Lunch |
14:10 |
Plenary Talk: “Communicating Statistics in an Expert Sceptical World” By Joy Leahy |
15:10 |
Parallel Session 2
- Public Sector, Government and Environmental Statistics Chair: Karen Tingay
- Kieran Bromley: Creating Updated Norms for Early Child Development in Developing Countries
- Gareth McCray: Sample Size and Stratum Weight Estimation for the Detection of Differential Item Functioning in Early Child Development Measures
- Zoe Craig: Is the Association Between Gestational Weight Gain and Macrosomia an Artefact of Tautology: A Simulation Study
- Xiaoyue Xi: Substantial Variation in HIV-1 Transmission Dynamics Over Small Geographic Scales in Rakai District, Uganda
- Clinical Trials Chair: Bethan Copsey
- Emily Robinson: Balancing Pragmatism, Transparency and Statistics in Randomised Controlled Trials: How to Approach an Over-Dispersed, Self-Reported, Count Outcome of a Complex Intervention
- Meredith Martyn: The Impact of Trial Design in Phase II Oncology Trials: A Comprehensive Review
- Laura Marsden: Open Cohort Designs in Institutional Settings: Findings From a Literature of Care Home Trials
- Harry Parr: Mixed-Effects Models to Characterise Prostate-Specific Antigen (PSA) Dynamics Post-Radiotherapy in the CHHiP Clinical Trial
|
16:30 |
Networking and Poster Session |
17:30 |
End of First Day |
19:00 |
Conference Dinner |